Oncology Institute (TOI) Gross Profit (2021 - 2025)
Historic Gross Profit for Oncology Institute (TOI) over the last 5 years, with Q3 2025 value amounting to $18.9 million.
- Oncology Institute's Gross Profit rose 3169.98% to $18.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $312.1 million, marking a year-over-year increase of 10942.12%. This contributed to the annual value of $206.5 million for FY2024, which is 4420.41% up from last year.
- According to the latest figures from Q3 2025, Oncology Institute's Gross Profit is $18.9 million, which was up 3169.98% from $68.7 million recorded in Q2 2025.
- In the past 5 years, Oncology Institute's Gross Profit registered a high of $167.2 million during Q4 2024, and its lowest value of $14.4 million during Q3 2024.
- Its 5-year average for Gross Profit is $41.5 million, with a median of $33.0 million in 2022.
- Over the last 5 years, Oncology Institute's Gross Profit had its largest YoY gain of 34669.46% in 2024, and its largest YoY loss of 6125.05% in 2024.
- Quarter analysis of 5 years shows Oncology Institute's Gross Profit stood at $25.0 million in 2021, then skyrocketed by 32.41% to $33.0 million in 2022, then increased by 13.26% to $37.4 million in 2023, then surged by 346.69% to $167.2 million in 2024, then plummeted by 88.68% to $18.9 million in 2025.
- Its Gross Profit was $18.9 million in Q3 2025, compared to $68.7 million in Q2 2025 and $57.3 million in Q1 2025.